Dr Susan O’Brien from MD Anderson Cancer Center, Houston, Texas, USA, chairs an interesting and stimulating symposium sponsored by Mundipharm International on issues affecting the management of CLL held during the 15th International Workshop on Chronic Lymphocytic Leukaemia – iwCLL – in September 2013. 

With the numerous major advances that have been made in CLL over the past few years come opportunities and challenges for patients and health care professionals.  These opportunities include improved PFS and OS; these challenges include which agents to select and how, which agents to use in combination, how to manage older/frail patients and how to pay for these newer therapies.  All these issues are addressed in this symposium by three international experts and a lively panel discussion that answers questions from the packed audience.

Content taken from a Mundipharma sponsored satellite symposium at iwCLL 2013 as part of the official programme.